Clinical Guidelines

Timely Scans May Reduce Mortality in Patients Who Present to the ER With Hematuria

One in 10 patients who present to the emergency room (ER) with visible hematuria die within 3 months, new research from the United Kingdom has indicated. The WASHOUT study found that a scan administer...

Share

Research from the WASHOUT study reveals that 10% of emergency patients with visible hematuria may die within three months. Conducted by Nikita R. Bhatt, the study presented at EAU26 shows that swift scanning within 48 hours not only reduces mortality rates but also facilitates quicker cancer diagnoses, particularly bladder cancer. With 25% of hematuria cases linked to cancer, inconsistencies in care highlight the need for real-world guidelines. A prompt CT or cystoscopy can be critical for effective management and outcomes.

Original Source(s)

Timely Scans May Reduce Mortality in Patients Who Present to the ER With Hematuria

  • by The ASCO Post Staff

  • March 18, 2026

Related Content

New AACR President-Elect and Board Members Announced

The American Association for Cancer Research (AACR) has announced that Robert H. Vonderheide, MD, DPhil, has been named the 2026–2027 AACR President-elect. Dr. Vonderheide is an renowned cancer immuno...

Neoadjuvant/Adjuvant Doublet Significantly Improved Survival in Patients With Muscle-Invasive Bladder Cancer

The combination of the NECTIN4-directed antibody drug conjugate enfortumab vedotin-ejfv and the immunotherapy drug pembrolizumab is the established first-line standard-of-care treatment for patients w...

Urine as a Cancer ‘Biopsy’?

Study traces tumor-derived extracellular vesicles from blood to urine through glomerular transport

  • March 18, 2026

  • 3 min